2022 Updates

  • 4/4/2022

    In this quarterly update, experts in infectious disease and immunology discuss key developments in COVID-19 since January 2022. In this interview, Drs. Leonard and Cassandra Calabrese highlight what we currently know regarding Omicron subvariant BA.2 and its response to available therapies. Faculty also provide updates on investigational therapies and summarize recent changes to the COVID-19 emergency use authorizations.

    Click here for interview transcript

  • 1/3/2022
    In this quarterly update, experts in infectious disease and immunology discuss key developments in COVID-19 management since October 2021. In this interview, Drs. Leonard and Cassandra Calabrese highlight the latest clinical data and summarize recent FDA approvals, emergency use authorizations, and guideline updates.

    Click here for interview transcript